Recent Publications

  1. Applying Findable, Accessible, Interoperable, and Reusable Principles to Biospecimens and Biobanks
    Rush A, Byrne JA, Watson PH. Biopreservation and Biobanking 12Feb2024, doi: 10.1089/bio.2023.0110.
  2. Biobanking and research quality: think locally, act globally
    Rush A, Watson PH, Byrne JA. Biopreservation and Biobanking 29Apr2023, doi: 10.1016/j.tig.2023.04.001
  3. What Do Biomedical Researchers Want from Biobanks? Results of an Online Survey
    Rush A,Catchpoole DR, Reaiche-Miller G, Gilbert T, Ng W, Watson PH, Byrne JA Biopreservation and Biobanking 20Jun2022, doi: 10.1089/bio.2021.0084.
  4. How Many Health Research Biobanks Are There?
    O'Donoghue S, Dee S, Byrne JA, Watson PH. Biopreservation and Biobanking 13 Jun 2022 https://doi.org/10.1089/bio.2021.0063
  5. Finding the Value in Biobanks: Enhancing the CTRNet Locator
    Matzke LA, Tarling TE, Gali B, Dee S, LeBlanc J, Vercauteren S, Watson PH. Biopreservation and Biobanking 19 Apr 2022 https://doi.org/10.1089/bio.2021.0043
  6. Analysis of Trends in Biospecimen Complexity in Cancer Research Over Two Decades
    Authours Biopreservation and Biobanking 19 Apr 2022 https://doi.org/10.1089/bio.2021.0078
  7. The Availability of Human Biospecimens to Support Biomarker Research
    Tarling TE, Byrne JA, Watson PH Biomark Insights 2022 Apr 19; doi:17:11772719221091750
  8. Vignettes to Illustrate the Value of Tumor Biobanks in Cancer Research in Canada
    Tarling TE, Matzke LA, Rush A, Gali B, Byrne JA, Watson PH. Biopreservation and Biobanking 15 Feb 2022 https://doi.org/10.1089/bio.2021.0002
  9. A Permission to Contact Platform Is an Efficient and Cost-Effective Enrollment Method for a Biobank to Create Study-Specific Research Cohorts
    Carvalho K, Gali B, LeBlanc J, Matzke LA, Watson PH. Biopreservation and Biobanking 13 Aug 2021 https://doi.org/10.1089/bio.2020.0114
  10. Building Research Support Capacity across Human Health Biobanks during the COVID-19 Pandemic
    Byrne JA, Carpenter JE, Carter C, Phillips K, Braye S, Watson PH, Rush A Biomark Insights 14Jun2021 doi: 110.1177/11772719211024100
  11. Biobanking for Cancer Biomarker Research: Issues and Solutions
    Matzke LA, Watson PH Biomark Insights 2020 Oct 19;15:1177271920965522. doi: 10.1177/1177271920965522. eCollection 2020.
  12. Improving Academic Biobank Value and Sustainability Through an Outputs Focus
    Rush A, Catchpoole DR, Ling R, Searles A, Watson PH, Byrne JA Value Health 23Aug2020 doi:10.1016/j.jval.2020.05.010.
  13. Precision medicine: Driving the evolution of biobanking quality
    Barnes RO, Watson PH. Healthc Manage Forum 2020 May;33(3):102-106. doi: 10.1177/0840470419898874. Epub 2020 Jan 20.
  14. Comparison and Analysis of Two Internationally Recognized Biobanking Standards
    Tarling TE, O'Donoghue S, Barnes, Carvalho K, Gali B, Castelhano M, Mes-Masson AM, Watson PH. Biopreservation and Biobanking 9 Apr 2020 https://doi.org/10.1089/bio.2019.0126
  15. UBCx “Biospecimen Research Methods Course”
    Matzke LA, O'Donoghue S, Watson PH Biopreservation and Biobanking 12 Feb 2020 https://doi.org/10.1089/bio.2019.0046
  16. Access ISBER Best Practice Education Online and Keep Your Practices Current
    Matzke LA, O'Donoghue S, Watson PH Biopreservation and Biobanking 2019 Dec;17(6):625-626. doi: 10.1089/bio.2019.29061.ljm. Epub 2019 Nov 19.
  17. A Review of International Biobanks and Networks: Success Factors and Key Benchmarks—A 10-Year Retrospective Review
    Devereux L, Watson PH, Mes-Masson AM, Luna-Crespo F, Thomas G, Pitman H, Speirs V, Hall AG, Bollinger N, Posada M, Lochmüller H, Thorne H, Chon Boonn E, Riegman PHJ, Ng W, Parry-Jones A. Biopreservation and Biobanking 11 Dec 2019, https://doi.org/10.1089/bio.2019.29060.djc.SI
  18. Canadian Tissue Repository Network Biobank Certification Program:Update and Review of the Program from 2011 to 2018.
    Victoria Hartman, Brent Gali, Simon Dee, Sheila O'Donoghue, Tamsin Tarling, Rebecca Barnes, Manon de Ladurantaye, Anne-Marie Mes-Masson, and Peter H. Watson. Biopreservation and Biobanking 2019 Jun
  19. Biospecimen Complexity and the Evolution of Biobanks.
    Hartman V, Matzke L, Watson PH. Biopreserv Biopreservation and Biobanking 2019 Jun; 17(3):264-70
  20. Biospecimen Data Reporting in the Research Literature.
    Meredith AJ, Simeon-Dubach D, Matzke LA, Cheah S, Watson PH. Biopreservation and Biobanking 2019 Apr 30
  21. Research Perspective on Utilizing and Valuing Tumor Biobanks.
    Rush A, Matzke L, et al. Biopreservation and Biobanking 2018 Dec 21.
  22. Business Planning for a Campus-Wide Biobank. Biopreserv Biobank.
    Tarling TE, Lasser F, Carter C, Matzke LA, et al. Biopreservation and Biobanking 2017 Feb;15(1):37-45
  23. Biospecimen user fees: global feedback on a calculator tool.
    Matzke L, Babinszky S, Slotty A, et al Biopreservation and Biobanking Feb;15(1):57-64
  24. Fundamental Considerations for Biobank Legacy Planning.
    Matzke Lise Anne Marie, Fombonne Benjamin, Watson Peter Hamilton, Moore Helen Marie. Biopreservation and Biobanking 2016 14:2, 99-106.
  25. A Model to Estimate Frozen Tissue Collection Targets in Biobanks to Support Cancer Research.
    Meredith Anna J., Slotty Alex, Matzke Lise, Babinszky Sindy, Watson Peter H. Biopreservation and Biobanking 2015 13:5, 356-362.
  26. The Importance of Biobanking in Cancer Research.
    astillo-Pelayo Tania, Babinszky Sindy, LeBlanc Jodi, Watson Peter H. Biopreservation and Biobanking 2015 13:3, 172-177..
  27. Critical issues in international biobanking.
    Vaught J, Abayomi A, Peakman T, Watson P, Matzke L, Moore H. Clin Chem. 2014 Nov;60(11):1368-74. PMID: 25098414.
  28. A Practical Tool for Modeling Biospecimen User Fees.
    Matzke L, Dee S, et al., Biopreservation and Biobanking. Biopreserv Biobank. 2014 Aug;12(4):234-9. PMID: 25162459
  29. Biobank classification: communicating biorepository diversity.
    Watson PH. Biopreservation and Biobanking. Biopreserv Biobank. 2014 Jun;12(3):163-4. PMID: 24955732
  30. Individual investigator profiles of biospecimen use in cancer research.
    Braun L, Lesperance M, Mes-Massons AM, Tsao MS, Watson PH. Biopreservation and Biobanking. Biopreserv Biobank. 2014 Jun;12(3):192-8. PMID: 24918606
  31. Biobanking 3.0: evidence based and customer focused biobanking.
    Simeon-Dubach D, Watson P. Clin Biochem. 2014 Mar;47(4-5):300-8. PMID: 24406300
  32. A Framework for Biobanking Sustainability.
    Watson PH, Nussbeck SY, et al. Biopreservation and Biobanking. Biopreserv Biobank. 2014; 12(1):60-68. PMID:24620771.
  33. Overcoming the translational roadblocks: a cancer care and research model.
    Braun L, Daudt HM, Watson P. Clin Transl Med. 2014 May 9;3:11. PMID: 24900890
  34. Generating a comprehensive set of standard operating procedures for a biorepository network-The CTRNet experience.
    Barnes R, Albert M, Damaraju S, de Sousa-Hitzler J, Kodeeswaran S, Mes-Masson AM, Watson P, Schacter B. Biopreserv Biobank. 2013 Dec;11(6):387-96. PMID: 24835369
  35. Permission to Contact (PTC) - A Strategy to Enhance Patient Engagement in Translational Research.
    Cheah S, O'Donoghue S, et al. Biopreservation and Biobanking. 2013; 11(4):245-252. PMID: 24845592.
  36. Impact of a 'Permission to Contact' (PTC) Platform on Biobank Enrollment and Efficiency.
    LeBlanc J, et al. Biopreservation and Biobanking. 2013; 11(3):144-149. PMID: 24850090.
  37. Specimen Quality Evaluation in Canadian Biobanks Participating in the COEUR Repository.
    Le Page C,Kobel M, de Ladurantaye M, et al. Biopreservation and Biobanking. 2013; 11(2): 83-93. PMID: 24845429.
  38. Biospecimen Use and Emerging Techniques in Cancer Research: Impact on Planning Future Biobanks.
    Cole A, Cheah S, Dee S, Hughes S, Barnes R, Watson PH. Biopreservation and Biobanking, 2012; 10(6):518-525. PMID: 24845138.
  39. An Online Tool for Improving Biospecimen Data Element Reporting.
    Cheah S, Dee S, et al. Biopreservation and Biobanking. 2012; 10:501-510. PMID 24845136.
  40. Certification for Biobanks: The Program Developed by the Canadian Tumour Repository Network (CTRNet).
    Matzke L, O'Donoghue S, et al. Biopreservation and Biobanking. 2011; 9:327-33. PMID: 24845043.
  41. Managing the Introduction of Biobanks to Potential Participants: Lessons from a Deliberative Public Forum.
    O'Doherty K, Ibrahim T, Hawkins A, Burgess M, Watson PH. Biopreservation and Biobanking, 2012; 10 (1):12-21. PMID: 24849749.
  42. A Proposed Schema for Classifying Human Research Biobanks.
    Watson PH, Barnes RO. Biopreservation and Biobanking. 2011; 9(4):327-333. PMID: 24836628.
  43. Canadian Tumour Repository Network. Biobank profiles.
    Watson, PH. Schacter B, Sawyer M, Mes-Messon M, Gibson S, Shepherd L, Kodeeswaran S. Biopreservation and Biobanking. 2010, 8(4):181-185. PMID: 24846103
  44. Biospecimen Use in Cancer Research Over Two Decades.
    Hughes SE, Barnes RO, Watson PH. Biopreservation and Biobanking. 2010; 8(2):89-97. PMID: 24845937
  45. Evolutionary concepts in biobanking - the BC BioLibrary.
    Watson PH, Wilson-McManus JE, et. al. J Transl Med. 2009 Nov 12;7:95. PMID: 19909513
  46. Influence of evolution in tumor biobanking on the interpretation of translational research.
    Barnes RO, Parisien M, Murphy LC, Watson PH. Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3344-50. PMID: 19064549